BROWSE·page 53 of 343

Browse EX-10 agreements

4,108 matching material contract exhibits.


EX-10.2

HAEMONETICS CORP

HAEMONETICS CORPORATION

AMENDED AND RESTATED 2007 EMPLOYEE STOCK PURCHASE PLAN

On May 15, 2026 (the “Effective Date”), the Board of Directors adopted this Amended and Restated 2007 Employee Stock Purchase Plan (as amended from time to time, the “Plan”), which shall govern all grants of options under the Plan made after the Effective Date. For the terms and conditions of the Plan applicable to an Option granted before the Effective Date, refer to the version of the Plan in effect as of the date such option was granted.

1.Purpose

It is the purpose of this Plan to provide a means whereby eligible employees may purchase Common Stock of Haemonetics Corporation (the “Company”) through payroll deductions. It is intended to provide a further incentive for employees to promote the best interests of the Company and to encourage stock ownership by employees in order that they may participate in the Company's economic growth.

EX-10.2·8-K·CIK 313143·ACC 0000313143-26-000095·Filed Jul 28, 2026, 16:28 ET

EX-10.1

HAEMONETICS CORP

HAEMONETICS CORPORATION

AMENDED AND RESTATED 2019 LONG-TERM INCENTIVE COMPENSATION PLAN

Effective as of the Effective Date (as defined below), the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan, as previously amended and restated, is hereby amended and restated (as further amended and restated, the “Plan”).

The purpose of the Plan is to provide employees of Haemonetics Corporation, a Massachusetts corporation (the “Company”), and its subsidiaries, certain consultants and advisors who perform services for the Company and its subsidiaries, and non-employee members of the Board of Directors of the Company and its subsidiaries, with the opportunity to receive grants of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards, and/or cash awards.

EX-10.1·8-K·CIK 313143·ACC 0000313143-26-000095·Filed Jul 28, 2026, 16:28 ET

EXHIBIT 10.3

AMERICAN SHARED HOSPITAL SERVICES

THIS PROMISSORY NOTE AND SECURITY AGREEMENT (NOTE) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ACT) OR UNDER ANY STATE SECURITIES LAW. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED EXCEPT PURSUANT TO THE PROVISIONS OF THE ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE BORROWER THAT SUCH SALE, ASSIGNMENT, PLEDGE OR TRANSFER IS IN COMPLIANCE WITH AN AVAILABLE EXEMPTION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS.

EX-10.3·8-K·CIK 744825·ACC 0001437749-26-024677·Filed Jul 28, 2026, 16:21 ET

EXHIBIT 10.1

AMERICAN SHARED HOSPITAL SERVICES

CERTAIN IDENTIFIED INFORMATION, MARKED BY [****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS OF THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

THIRD AMENDMENT TO CREDIT AGREEMENT AND FORBEARANCE AGREEMENT

This THIRD AMENDMENT TO CREDIT AGREEMENT AND FORBEARANCE AGREEMENT (this “Amendment”) is entered into as of July 22, 2026, by and among AMERICAN SHARED HOSPITAL SERVICES, a California corporation (“ASHS”), PBRT ORLANDO, LLC, a Delaware limited liability company (“PBRT Orlando”), and GK FINANCING, LLC, a California limited liability company and indirect Subsidiary of ASHS (“GKF”; ASHS, PBRT Orlando and GKF are from time to time referred to herein individually as a “Borrower”* *and collectively as the “Borrowers”), FIFTH THIRD BANK, NATIONAL ASSOCIATION (“Lender”), and AMERICAN SHARED RADIOSURGERY SERVICES, a California corporation, as a Loan Party.

W I T N E S S E T H:

EX-10.1·8-K·CIK 744825·ACC 0001437749-26-024677·Filed Jul 28, 2026, 16:21 ET

EXHIBIT 10.2

AMERICAN SHARED HOSPITAL SERVICES

NOTE AND WARRANT PURCHASE AGREEMENT

This Note and Warrant Purchase Agreement, dated as of July 22, 2026 (this “Agreement”) is entered into between and among American Shared Hospital Services, a California corporation (the “Company” or the “Borrower”), and RCS/TIG Holdings LLC, a Delaware limited liability company (the “Lender”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the form of Note (as defined below) or Warrant (as defined below) attached hereto as Exhibits A and B, respectively.

RECITALS

WHEREAS, the Borrower has requested that the Lender invest the sum of $2,000,000 (the “Loan) in return for: (i) a promissory note in the principal amount of the Loan and (ii) certain warrants to purchase shares of Company Common Stock No Par Value (the “Common Stock”), and the Lender is willing to make the Loan on the terms and conditions set forth herein (the “Note and Warrant Purchase”);

EX-10.2·8-K·CIK 744825·ACC 0001437749-26-024677·Filed Jul 28, 2026, 16:21 ET

EX-10.1

Apple Hospitality REIT, Inc.

Published Deal CUSIP: 03785AAQ5

Published Revolver CUSIP: 03785AAR3

Published Term A-1 CUSIP: 03785AAS1

Published Term A-2 CUSIP: 03785AAT9

FOURTH AMENDED AND RESTATED CREDIT AGREEMENT

Dated as of July 23, 2026

among

APPLE HOSPITALITY REIT, INC.,

as the Borrower,

CERTAIN SUBSIDIARIES OF APPLE HOSPITALITY REIT, INC.
FROM TIME TO TIME PARTY HERETO,
as Guarantors,

BANK OF AMERICA, N.A.,
as Administrative Agent,

WELLS FARGO BANK, NATIONAL ASSOCIATION,

KEYBANK NATIONAL ASSOCIATION and U.S. BANK NATIONAL ASSOCIATION,

as Co-Syndication Agents

PNC BANK, NATIONAL ASSOCIATION, andTRUIST BANK,

as Documentation Agents

BMO BANK, N.A. andREGIONS BANK,

as Managing Agents

and

The Lenders and L/C Issuers Party Hereto

BofA SECURITIES, INC.,

WELLS FARGO SECURITIES, LLC,
KEYBANC CAPITAL MARKETS,
U.S. BANK NATIONAL ASSOCIATION,
PNC CAPITAL MARKETS LLC,
and
TRUIST BANK,
as Joint Lead Arrangers

BofA SECURITIES, INC.,

WELLS FARGO SECURITIES, LLC,
KEYBANC CAPITAL MARKETS,
U.S. BANK NATIONAL ASSOCIATION,
as Joint Bookrunners


TABLE OF CONTENTS

SectionPage

EX-10.1·8-K·CIK 1418121·ACC 0001193125-26-321027·Filed Jul 28, 2026, 16:15 ET

EX-10.2

EchoStar CORP

EX-10·8-K·CIK 1415404·ACC 0001415404-26-000035·Filed Jul 28, 2026, 16:14 ET

EXHIBIT 10.1

Entera Bio Ltd.


Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 26, 2026, between Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each purchaser, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

EX-10.1·8-K·CIK 1638097·ACC 0001178913-26-003617·Filed Jul 28, 2026, 16:12 ET

EXHIBIT 10.3

Entera Bio Ltd.


Exhibit 10.3

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 28, 2026, between Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of July 26, 2026, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agrees as follows:

1.             Definitions.

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the respective meanings given to such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

Advice” shall have the meaning set forth in Section ‎6(b).

EX-10.3·8-K·CIK 1638097·ACC 0001178913-26-003617·Filed Jul 28, 2026, 16:12 ET

EXHIBIT 10.2

Entera Bio Ltd.


Exhibit 10.2

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT

ENTERA BIO LTD.

EX-10.2·8-K·CIK 1638097·ACC 0001178913-26-003617·Filed Jul 28, 2026, 16:12 ET

EXHIBIT 10.7

Ford Credit Auto Lease Two LLC

Exhibit 10.7

Execution Version

ADMINISTRATION AGREEMENT

between

FORD CREDIT AUTO LEASE TRUST 2026-B,
as Issuer,

and

FORD MOTOR CREDIT COMPANY LLC,
as Administrator

Dated as of July 1, 2026

TABLE OF CONTENTS

ARTICLE I USAGE AND DEFINITIONS 1
Section 1.1. Usage and Definitions 1
ARTICLE II ADMINISTRATION OF ISSUER 1
Section 2.1. Engagement of Administrator 1

EX-10.7·8-K·CIK 1519881·ACC 0001104659-26-087481·Filed Jul 28, 2026, 14:45 ET

EXHIBIT 10.8

Ford Credit Auto Lease Two LLC

Exhibit 10.8

Execution Version

ACCOUNT CONTROL AGREEMENT

among

FORD CREDIT AUTO LEASE TRUST 2026-B
as Grantor

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,
as Secured Party

and

U.S. BANK NATIONAL ASSOCIATION,
as Financial Institution

Dated as of July 1, 2026

TABLE OF CONTENTS

ARTICLE I USAGE AND DEFINITIONS 1
Section 1.1. Usage and Definitions 1
ARTICLE II ESTABLISHMENT OF COLLATERAL ACCOUNT 1
Section 2.1. Description of Account 1

EX-10.8·8-K·CIK 1519881·ACC 0001104659-26-087481·Filed Jul 28, 2026, 14:45 ET